CPX-351 (VYXEOS)
A Prospective, Single Site, Single-Arm Pilot Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 25 patients (estimated)
- Sponsors
- St. Jude Children's Research Center
- Collaborators
- Jazz Pharmaceuticals
- Tags
- Allogeneic Stem Cell Transplant, Chemotherapy, Steroid
- Trial Type
- Treatment
- Last Update
- 1 month ago
- SparkCures ID
- 1670
- NCT Identifier
- NCT05656248
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.